Centro Risorse

Questa sezione contiene ricerche internazionali e può fare riferimento a indicazioni non approvate in tutte le regioni. Si prega di consultare le indicazioni approvate localmente prima dell’uso.

Filtra per:

Cerca

Click On The Read More Below To Request The Document

Click On The Read More Below To Request The Document

Click on the read more below to request the document

OMER, Israel, Feb 2, 2026 /PRNewswire/ — Pulsenmore Ltd. (NASDAQ, TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in the

Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month

We’re excited to share a few key updates from Pulsenmore as we continue to expand our impact in maternal-fetal care. FDA authorization, and what it unlocks Receiving FDA De Novo

L’impulso delle notizie

Vi invitiamo a rimanere informati sugli ultimi aggiornamenti iscrivendovi alla nostra newsletter trimestrale

Domande frequenti

Domande frequenti